Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1975-9-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-1591
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
255
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-14
|
pubmed:dateRevised |
2008-2-15
|
pubmed:meshHeading |
pubmed-meshheading:4618720-Clinical Trials as Topic,
pubmed-meshheading:4618720-Female,
pubmed-meshheading:4618720-Flupenthixol,
pubmed-meshheading:4618720-Humans,
pubmed-meshheading:4618720-Paranoid Disorders,
pubmed-meshheading:4618720-Placebos,
pubmed-meshheading:4618720-Schizophrenia,
pubmed-meshheading:4618720-Thioxanthenes,
pubmed-meshheading:4618720-Time Factors
|
pubmed:year |
1974
|
pubmed:articleTitle |
Flupenthixol decanoate - controlled investigation concerning dosage -.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|